506879 Share Price Performance
₹0
-328.10 (-100.00%)
Price ₹0
Share Pricen/a
Gujarat Themis Biosyn Limited Stock Price
- 0 Narratives written by author
- 0 Comments on narratives written by author
- 3 Fair Values set on narratives written by author
506879 Community Narratives
There are no narratives available yet.
There are no community narratives available.
Recently Updated Narratives
No recently updated narratives available.
Snowflake Analysis
Gujarat Themis Biosyn Limited Key Details
Last Reported Earnings
Sep 30, 2025
Next Reporting Earnings
Feb 14, 2026
- 4.43
- 60.89%
- 31.06%
- 26.1%
About 506879
- Founded
- 1981
- Employees
- 221
- CEO
- WebsiteView website
Gujarat Themis Biosyn Limited engages in the manufacture of pharmaceuticals and medicinal chemicals in India. The company offers bulk drugs on job work basis in India. Its products include Rifamycin-S, an intermediate for the treatment of tuberculosis, Mycobacterium avium complex, leprosy, and Legionnaires' disease; Rifamycin-O for the treatment of traveler's diarrhea, irritable bowel syndrome, and hepatic encephalopathy; and Lovastatin. The company was incorporated in 1981 and is based in Mumbai, India.
